空カプセル市場 – 2030年までの世界予測

この調査レポートでは、空カプセル市場を、タイプ（ゼラチンカプセル、非ゼラチンカプセル）、原材料（ゼラチン[豚由来ゼラチン、牛由来ゼラチン、骨粉由来ゼラチン、その他のゼラチン源]、非ゼラチン[hpmc、プルラン、デンプン]）、機能（即放性、徐放性、遅延放出性）、サイズ（サイズ000、サイズ00、サイズ0、サイズ1、サイズ2、サイズ3、サイズ4、サイズ5）、治療用途（抗生物質および抗菌薬、栄養補助食品、制酸剤および鼓腸剤、抗貧血剤、抗炎症薬、心血管治療薬、咳止めおよび風邪薬、その他の治療用途）、エンドユーザー（製薬業界、栄養補助食品業界、化粧品業界、研究機関）および地域（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）。
本レポートは、空カプセル市場の成長に影響を与える推進要因、制約要因、課題、機会といった主要な要因に関する詳細な情報を網羅しています。主要業界プレーヤーを徹底的に分析し、事業概要、製品、そして新製品の発売、コラボレーション、パートナーシップ契約を含む主要戦略に関する洞察を提供しています。

本レポートは、空カプセル市場全体とそのサブセグメントにおける収益の詳細な推定値を提供することで、市場リーダー企業と新規参入企業を支援します。また、ステークホルダーが競争環境をより深く理解し、より効果的な事業ポジショニングと適切な市場開拓戦略の策定に役立つ洞察を得るのに役立ちます。本レポートは、ステークホルダーが市場の動向を把握し、市場における主要な推進要因、制約要因、機会、課題に関する情報を提供することを可能にします。

世界の空カプセル市場は、2025年の推定31億9,000万米ドルから2030年には41億9,000万米ドルに達し、2025年から2030年にかけて5.6%の年平均成長率（CAGR）で成長すると予測されています。市場は、栄養補助食品やパーソナライズサプリメントの需要増加、医薬品研究開発の進展、機能性カプセルや徐放性カプセルのイノベーションによって牽引されています。ベジタリアン向けやクリーンラベル製品への大きなシフト、そして持続可能性を重視した規制も、この市場への導入をさらに促進しています。今後の成長は、新興市場における現地生産と生分解性カプセルの開発によってもたらされる可能性が高いでしょう。

The global empty capsules market is projected to reach USD 4.19 billion by 2030 from an estimated USD 3.19 billion in 2025, at a CAGR of 5.6% from 2025 to 2030. The market is fueled by increasing demand for nutraceuticals and personalized supplements, growth in pharmaceutical R&D, and innovations in functional and modified-release capsules. A significant shift toward vegetarian and clean-label options and sustainability-focused regulations is further driving adoption. Future growth is likely to come from localized production in emerging markets and the creation of biodegradable capsules.

“The porcine-derived capsules will continue to be the largest raw material segment in the gelatin capsules market, growing at the highest CAGR.”

The gelatin empty capsules market is segmented based on raw material into porcine gelatin, bovine-derived gelatin, bone meal, and other gelatin sources. The non-gelatin capsules market is further categorized into hydroxypropyl methylcellulose (HPMC) and pullulan & starch. The porcine gelatin capsule market is the largest raw material category and is expected to experience the highest growth rate during the forecast period, due to its cost-effectiveness and wide availability. Porcine gelatin is widely used in the pharmaceutical and nutraceutical industries because of its excellent gelling properties, making it suitable for various drug formulations, including solid and controlled-release types.

“Pharmaceutical industry segment reported the highest share of the end user segment in 2024.”

Based on end users, the empty capsules market is categorized into pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories. The pharmaceutical industry is the largest end user of empty capsules, widely using them for delivering prescription drugs, over-the-counter (OTC) medications, and therapeutic treatments. These capsules are commonly used for oral administration of solid drugs like antibiotics, pain relievers, antihypertensives, and other medications for managing chronic diseases. Capsules are a preferred dosage form in the pharmaceutical sector because they are easy to swallow, provide accurate dosing, and can encapsulate a broad range of drugs.

North America accounted for the largest global empty capsules market from 2025 to 2030.

In 2024, North America, especially the US and Canada, will be the largest market for empty capsules due to strong demand in pharmaceuticals and nutraceuticals, supported by advanced manufacturing infrastructure and robust regulatory frameworks. Ongoing investments in technology and innovation have led to the development of high-quality capsules for various applications, such as immediate and controlled-release drug delivery. The rising demand for dietary supplements, driven by consumer interest in preventive healthcare and wellness, further fuels market growth. The region also benefits from a favorable regulatory environment, which encourages the adoption of new drug delivery formats, including controlled-release and enteric-coated capsules. Additionally, the Asia Pacific region is expected to see the fastest growth during this period, thanks to expanding pharmaceutical manufacturing capabilities, lower production costs, and supportive government policies. Countries like China, India, and South Korea are becoming key manufacturing hubs due to their large skilled labor pools, low costs, and favorable policies.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side-70% and Demand Side-30%
• By Designation: Managers-45%, CXO and Directors-30%, and Executives-25%
• By Region: North America-40%, Europe-25%, the Asia Pacific-20%, Latin America-10%, and the Middle East & Africa-5%

List of Key Companies Profiled in the Report:

Key players in the Empty capsules market include Lonza (Capsugel) (Switzerland), ACG (India), Suheung (South Korea), Roquette (Qualicaps) (France), Shanxi Guangsheng Medicinal Capsule Co., Ltd (China), Nectar Lifesciences (India), Sunil Healthcare (India), Natural Capsules Limited (India), Baotou Dongbao Bio-Tech Co Ltd. (China), Anhui Huangshan Capsule Co., Ltd. (China), CapsCanada(Lyfe Group) (Canada), Farmacapsulas (Colombia), Healthcaps India (India), Erawat Pharma (India), Comed Chemicals Ltd (India), Fortcaps Healthcare Limited (India), and Shandong Healsee Capsule Ltd. (China).

Research Coverage:

This research report categorizes the empty capsules market, by type (gelatin capsules, non-gelatin capsules), by raw materials (gelatin [porcine-derived gelatin, bovine-derived gelatin, bone meal-derived gelatin, other gelatin sources], non-gelatin [hpmc, pullulan & starch]), functionality (immediate-release, sustained-release, delayed-release), size (Size 000, Size 00, Size 0, Size 1, Size 2, Size 3, Size 4, Size 5), therapeutic application (antibiotic & antibacterial drugs, dietary supplements, antacid & ant flatulent preparations, anti-anaemic preparations, anti-inflammatory drugs,  cardiovascular therapy drugs, cough & cold drugs, other therapeutic applications), end user (pharmaceutical industry, nutraceutical industry, cosmetic industry, research laboratories) and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The scope of the report covers detailed information about major factors such as drivers, restraints, challenges, and opportunities that influence the growth of the empty capsules market. A thorough analysis of key industry players has been conducted to provide insights into their business overview, products, and key strategies, including new product launches, collaborations, and partnership agreements.

Key Benefits of Buying the Report:

The report will assist market leaders and new entrants by providing close estimates of revenue in the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to more effectively position their businesses and develop appropriate go-to-market strategies. This report will enable stakeholders to grasp the market’s pulse and offer information on the key drivers, restraints, opportunities, and challenges within the market.

The report provides insights on the following pointers:

• Analysis of key drivers (growth in nutraceuticals & personalized supplements market, growing focus on pharmaceutical development and subsequent increase in clinical trials, expansion of functional & modified-release capsules, sustainability & regulatory-driven transition, increasing preference for self-medication and OTC drugs, shift toward vegetarian & clean-label capsules) restraints (dietary restrictions associated with gelatin consumption, issues related to safety and efficacy, competition from other drug delivery technologies), opportunities (geographic expansion & localized production in emerging economies, development of biodegradable and sustainable capsules), and challenges (challenges associated with logistics and storage of empty capsules, raw material availability & supply chain dependence)
• Product Development/Innovation: Detailed insights on upcoming products, technologies, research & development activities in the empty capsules market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the empty capsules market
• Competitive Assessment: In-depth assessment of market shares, company revenue, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/approvals, acquisitions, partnerships, agreements, collaborations, expansions, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the empty capsules market.

Table of Contents

1               INTRODUCTION              41

1.1           STUDY OBJECTIVES       41

1.2           MARKET DEFINITION   41

1.3           STUDY SCOPE   42

1.3.1        EMPTY CAPSULES MARKET SEGMENTATION & REGIONAL SCOPE            42

1.3.2        INCLUSIONS & EXCLUSIONS       43

1.3.3        YEARS CONSIDERED      43

1.3.4        UNITS CONSIDERED      44

1.3.4.1    Currency/Value units          44

1.3.4.2    Volume units         44

1.4           STAKEHOLDERS               44

1.5           SUMMARY OF CHANGES               44

2               RESEARCH METHODOLOGY       46

2.1           RESEARCH APPROACH  46

2.1.1        SECONDARY DATA          47

2.1.1.1    Key sources of secondary data            47

2.1.1.2    Key objectives of secondary research                 47

2.1.2        PRIMARY DATA 48

2.1.2.1    Breakdown of primaries      48

2.1.2.2    Key objectives of primary research    48

2.2           MARKET ESTIMATION METHODOLOGY               49

2.2.1        GLOBAL EMPTY CAPSULES MARKET ESTIMATION, 2024                 49

2.2.1.1    Company revenue analysis (bottom-up approach)         49

2.2.1.2    Volume-based estimation    50

2.2.1.3    MNM repository analysis    52

2.2.1.4    Primary research  52

2.2.2        SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH)       53

2.3           MARKET GROWTH RATE PROJECTIONS                54

2.4           DATA TRIANGULATION                57

2.5           STUDY ASSUMPTIONS  58

2.6           RESEARCH LIMITATIONS             59

2.7           RISK ANALYSIS  59

3               EXECUTIVE SUMMARY  60

3.1           KEY INSIGHTS AND MARKET HIGHLIGHTS          60

3.2           STRATEGIC IMPERATIVES FOR STAKEHOLDERS IN EMPTY CAPSULES MARKET         66

3.3           DISRUPTIVE TRENDS SHAPING EMPTY CAPSULES MARKET               67

4               PREMIUM INSIGHTS       68

4.1           SNAPSHOT: GLOBAL EMPTY CAPSULES MARKET, CAGR, AND FORECAST (2025–2030)         68

4.2           NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2024)    69

4.3           EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION (2024)       69

4.4           EMPTY CAPSULES MARKET, BY END USER (2024)                 70

4.5           EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              70

5               MARKET OVERVIEW       71

5.1           INTRODUCTION              71

5.2           MARKET DYNAMICS       71

5.2.1        DRIVERS               73

5.2.1.1    Increasing demand for nutraceuticals and personalized supplements          73

5.2.1.2    Growing focus on pharmaceutical development and increase in clinical trials          73

5.2.1.3    Increased demand for functional and modified-release capsules in pharmaceutical and nutraceutical industries                75

5.2.1.4    Advancements in capsule delivery technologies               75

5.2.1.5    Shift toward vegetarian, vegan, and clean-label capsules                 76

5.2.1.6    Growing preference for self-medication and OTC drugs                 76

5.2.2        RESTRAINTS      77

5.2.2.1    Dietary restrictions associated with gelatin consumption                 77

5.2.2.2    Issues related to safety and efficacy of gelatin capsules 77

5.2.2.3    Competition from alternative drug delivery technologies                 78

5.2.3        OPPORTUNITIES              78

5.2.3.1    Geographic expansion and localized production in emerging economies              78

5.2.3.2    Development of biodegradable and sustainable capsules in life sciences industry  79

5.2.4        CHALLENGES    79

5.2.4.1    Challenges associated with logistics and storage of empty capsules 79

5.2.4.2    Lack of adequate raw material and increased supply chain dependence            80

5.3           INDUSTRY TRENDS         80

5.3.1        AI-INTEGRATED AND PERSONALIZED DRUG AND SUPPLEMENT FORMULATION AND DOSING      80

5.3.2        ON-DEMAND MANUFACTURING SYSTEMS AND DECENTRALIZED CAPSULE-BASED FORMULATIONS IN CLINICAL TRIALS             80

5.3.3        INTEGRATION OF SMART CAPSULES AND INGESTIBLE SENSORS IN CLINICAL RESEARCH            81

5.4           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       81

5.5           PRICING ANALYSIS          82

5.5.1        AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE, 2022−2024        82

5.5.2        AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY REGION, 2022−2024  83

5.5.3        FACTORS IMPACTING EMPTY CAPSULES PRICING                 84

5.6           TECHNOLOGY ANALYSIS             85

5.6.1        KEY TECHNOLOGIES     85

5.6.1.1    Advanced quality control systems      85

5.6.1.2    Automated encapsulation machines  85

5.6.2        COMPLEMENTARY TECHNOLOGIES       86

5.6.2.1    3D printing            86

5.6.2.2    Enteric capsule technologies               86

5.6.3        ADJACENT TECHNOLOGIES       86

5.6.3.1    Nanotechnology    86

5.6.3.2    AI in capsule manufacturing               87

5.7           VALUE CHAIN ANALYSIS               87

5.8           ECOSYSTEM ANALYSIS  89

5.8.1        RAW MATERIAL VENDORS           89

5.8.2        PRODUCT PROVIDERS  90

5.8.3        END USERS         90

5.8.4        REGULATORY AUTHORITIES     91

5.8.5        EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFT                 91

5.9           PORTER’S FIVE FORCES ANALYSIS           93

5.9.1        THREAT OF NEW ENTRANTS      94

5.9.2        THREAT OF SUBSTITUTES          94

5.9.3        BARGAINING POWER OF SUPPLIERS       94

5.9.4        BARGAINING POWER OF BUYERS             94

5.9.5        INTENSITY OF COMPETITIVE RIVALRY 95

5.10         KEY STAKEHOLDERS & BUYING CRITERIA            95

5.10.1      KEY STAKEHOLDERS IN BUYING PROCESS           95

5.10.2      KEY BUYING CRITERIA  97

5.10.3      ADOPTION BARRIER & INTERNAL FRICTION      99

5.11         PATENT ANALYSIS          99

5.11.1      PATENT METHODOLOGY            99

5.11.2      NUMBER OF PATENTS FILED, BY DOCUMENT TYPE                 99

5.11.3      INNOVATION & PATENT APPLICATIONS              100

5.11.4      TOP APPLICANTS            100

5.11.5      INDICATIVE LIST OF PATENTS  101

5.12         KEY CONFERENCES & EVENTS, 2025–2026              103

5.13         TRADE ANALYSIS             104

5.13.1      IMPORT AND EXPORT DATA FOR HS CODE 960200                 104

5.13.1.1  Import data for HS code 960200, 2020−2024                 104

5.13.1.2  Export data for HS code 960200, 2020−2024 105

5.13.2      IMPORT AND EXPORT VOLUME FOR HS CODE 960200                 106

5.13.2.1  Import volume for HS code 960200, 2020–2024              106

5.13.2.2  Export volume for HS code 960200, 2020–2024              107

5.14         TARRIF DATA & REGULATORY ANALYSIS             108

5.14.1      TARIFF DATA ANALYSIS                108

5.14.2      REGULATORY FRAMEWORK       108

5.14.2.1  Manufacturing process standards      108

5.14.2.2  Regulations for capsule supplier change           110

5.14.2.3  Regulatory information on colorants 110

5.14.3      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             110

5.14.4      REGULATORY CHALLENGES      114

5.14.5      SUSTAINABILITY IMPACT            115

5.15         CUSTOMER LANDSCAPE               116

5.15.1      UNMET NEEDS & WHITE SPACES              116

5.15.2      CAPSULE PURCHASE/PROCUREMENT MODELS                 116

5.15.3      BUDGET ALLOCATION TREND 116

5.15.4      STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES                 117

5.16         INVESTMENT & FUNDING SCENARIO     118

5.17         IMPACT OF AI/GEN AI ON EMPTY CAPSULES MARKET                 120

5.17.1      MARKET POTENTIAL OF AI IN EMPTY CAPSULES PRODUCTION   120

5.17.2      AI USE CASES     121

5.17.3      KEY COMPANIES IMPLEMENTING AI      121

5.17.4      FUTURE OF GENERATIVE AI IN EMPTY CAPSULES ECOSYSTEM       122

5.18         IMPACT OF 2025 TRUMP TARIFF ON EMPTY CAPSULES MARKET               122

5.18.1      INTRODUCTION              122

5.18.2      KEY TARIFF RATES          123

5.18.3      PRICE IMPACT ANALYSIS             124

5.18.4      IMPACT ON COUNTRY/REGION                124

5.18.4.1  North America      124

5.18.4.1.1                US           124

5.18.4.2  Europe   124

5.18.4.3  Asia Pacific            125

5.18.5      IMPACT ON END-USE INDUSTRIES          125

5.18.5.1  Pharmaceutical & biotech companies                125

5.18.5.2  Nutraceutical industry         126

5.18.5.3  Cosmetic industry                 126

5.19         EMPTY CAPSULES MANUFACTURING PROCESS 126

5.19.1      SOURCING OF RAW MATERIAL  126

5.19.1.1  Identify source      126

5.19.1.2  Impact of source variation on product quality 127

5.19.1.3  Certification for sustainable and ethical sourcing           127

5.19.1.4  Impact of market dynamics on raw material sourcing    127

5.19.1.5  Role of industry associations on raw material sourcing  127

5.19.2      PROCESSING     128

5.19.3      QUALITY CONTROL & PACKAGING         128

5.20         EMPTY CAPSULES PRODUCTION CAPACITY       129

5.21         INTERCONNECTED MARKET: INSIGHTS ON PHARMACEUTICAL GELATIN MARKET  130

6               EMPTY CAPSULES MARKET, BY TYPE     131

6.1           INTRODUCTION              132

6.2           GELATIN CAPSULES       132

6.2.1        PROVEN SAFETY, VERSATILITY, EASE OF MANUFACTURING, QUICK DISINTEGRATION, AND HIGH BIOAVAILABILITY TO DRIVE ADOPTION              132

6.2.2        GELATIN EMPTY CAPSULES VOLUME MARKET, BY REGION                136

6.3           NON-GELATIN CAPSULES            137

6.3.1        SHIFT OF CONSUMER DEMAND TOWARD CLEAN-LABEL, VEGAN, AND SUSTAINABLE SOLUTIONS TO PROPEL MARKET GROWTH          137

6.3.2        NON-GELATIN EMPTY CAPSULES VOLUME MARKET, BY REGION                141

7               EMPTY CAPSULES MARKET, BY RAW MATERIAL                 142

7.1           INTRODUCTION              143

7.2           GELATIN CAPSULES MARKET, BY RAW MATERIAL                 143

7.2.1        PORCINE GELATIN          143

7.2.1.1    Cost-effectiveness, high availability, and quick dissolving properties to support use in hard capsule production    143

7.2.2        BOVINE-DERIVED GELATIN        147

7.2.2.1    Reduced cattle slaughter to limit market growth             147

7.2.3        BONEMEAL GELATIN     150

7.2.3.1    Rising demand for bonemeal capsules in pharmaceutical industry to encourage market growth                150

7.2.4        OTHER GELATIN SOURCES         154

7.3           NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL                 157

7.3.1        HYDROXYPROPYL METHYLCELLULOSE (HPMC)                 157

7.3.1.1    Chemical & thermal stability, faster dissolution, and low brittleness in low humidity to favor market growth         157

7.3.2        PULLULAN & STARCH    161

7.3.2.1    Increasing demand for transparent, vegan, and non-GMO capsules to accelerate market growth                 161

8               EMPTY CAPSULES MARKET, BY FUNCTIONALITY                 165

8.1           INTRODUCTION              166

8.2           IMMEDIATE-RELEASE CAPSULES              166

8.2.1        RAPID ABSORPTION, LOW PRODUCTION COST, AND BROAD APPLICATIONS TO AUGMENT MARKET GROWTH                 166

8.3           SUSTAINED-RELEASE CAPSULES               170

8.3.1        CONTROLLED DRUG RELEASE FOR CHRONIC DISEASE MANAGEMENT TO SPUR MARKET GROWTH       170

8.4           DELAYED-RELEASE CAPSULES  173

8.4.1        DEMAND FOR ENTERIC-COATED CAPSULES AND ADVANCEMENTS IN PH-SENSITIVE POLYMER COATINGS TO DRIVE MARKET 173

9               EMPTY CAPULES MARKET, BY SIZE         177

9.1           INTRODUCTION              178

9.2           SIZE 0    178

9.2.1        RISING DEMAND FOR MID-DOSE FORMULATIONS TO FUEL MAKET GROWTH 178

9.3           SIZE 00  182

9.3.1        INCREASED NEED FOR ENCAPSULATING SINGLE-DOSE HERBAL EXTRACTS TO BOOST MARKET GROWTH           182

9.4           SIZE 1    185

9.4.1        NEED FOR COMPACT, LOW-TO-MID DOSE FORMULATIONS WITH HIGH SWALLOWABILITY TO BOOST ADOPTION         185

9.5           SIZE 2    189

9.5.1        DOSE ACCURACY, COMPATIBILITY WITH DIETARY PREFERENCES, AND STANDARD MANUFACTURING EQUIPMENT TO SPUR MARKET 189

9.6           SIZE 000                 192

9.6.1        POPULARITY OF HIGH-DOSE CAPSULES IN SPORTS NUTRITION, FUNCTIONAL MEDICINES, AND HERBAL FORMULATIONS TO DRIVE MARKET      192

9.7           SIZE 3    196

9.7.1        NEED FOR PRECISE AND LOW-DOSE DELIVERY TO AUGMENT MARKET GROWTH   196

9.8           SIZE 4    199

9.8.1        FOCUS ON DOSE PERSONALIZATION AND PATIENT-CENTRIC CARE TO FUEL ADOPTION IN PEDIATRIC DOSING AND GERIATRIC MEDICATIONS                199

9.9           SIZE 5    202

9.9.1        MINIMAL CAPACITY AND SMALL FOOTPRINT TO BE USEFUL IN SPECIALTY SEGMENTS           202

10            EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION   205

10.1         INTRODUCTION              206

10.2         ANTIBIOTIC & ANTIBACTERIAL DRUGS                 206

10.2.1      HIGH INCIDENCE OF INFECTIOUS DISEASES AND FOCUS ON INNOVATIVE CAPSULE FORMULATIONS TO DRIVE MARKET               206

10.3         DIETARY SUPPLEMENTS              210

10.3.1      HIGH UPTAKE OF MULTIVITAMINS TO BOOST MARKET DEMAND             210

10.4         ANTACID & ANTIFLATULENT PREPARATIONS   213

10.4.1      POPULARITY OF GENERIC MEDICATIONS AND LIFESTYLE CHANGES IN EMERGING ECONOMIES TO SPUR MARKET GROWTH          213

10.5         ANTIANEMIC PREPARATIONS    217

10.5.1      RISING PREVALENCE OF ANEMIA TO SUPPORT MARKET FOR IRON & FOLIC ACID DEFICIENCY CAPSULES              217

10.6         ANTI-INFLAMMATORY DRUGS  220

10.6.1      EXPANSION OF GENERIC THERAPEUTICS MARKET FOR OBESITY TO PROPEL MARKET GROWTH               220

10.7         CARDIOVASCULAR THERAPY DRUGS     223

10.7.1      SEDENTARY LIFESTYLE AND HIGH PREVALENCE OF DIABETES TO BOOST MARKET GROWTH              223

10.8         COUGH & COLD DRUGS                227

10.8.1      RISING ENVIRONMENTAL POLLUTION AND INCREASING NUMBER OF PASSIVE SMOKERS TO FAVOR MARKET GROWTH          227

10.9         OTHER THERAPEUTIC APPLICATIONS  230

11            EMPTY CAPSULES MARKET, BY END USER           234

11.1         INTRODUCTION              235

11.2         PHARMACEUTICAL INDUSTRY  235

11.2.1      INCREASING FOCUS ON ADVANCED DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET GROWTH            235

11.3         NUTRACEUTICAL INDUSTRY     239

11.3.1      GROWING DEMAND FOR DIETARY SUPPLEMENTS TO BOOST MARKET DEMAND           239

11.4         COSMETIC INDUSTRY   243

11.4.1      RISING FOCUS ON PERSONALIZED BEAUTY AND HOLISTIC WELLNESS TO SUPPORT MARKET GROWTH  243

11.5         RESEARCH LABORATORIES         246

11.5.1      GROWING FOCUS ON CLINICAL TRIALS TO SUPPORT ADOPTION IN PRECISE DOSING AND PHARMACEUTICAL TESTING              246

12            EMPTY CAPSULES MARKET, BY REGION                250

12.1         INTRODUCTION              251

12.1.1      GLOBAL EMPTY CAPSULES MARKET VOLUME   251

12.2         NORTH AMERICA             252

12.2.1      NORTH AMERICAN EMPTY CAPSULES VOLUME MARKET, BY TYPE           253

12.2.2      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 254

12.2.3      US           258

12.2.3.1  US to dominate North American empty capsules market during forecast period      258

12.2.4      CANADA               262

12.2.4.1  Rising per capita healthcare spending and growing elderly population to propel market growth  262

12.3         EUROPE               266

12.3.1      EUROPEAN EMPTY CAPSULES VOLUME MARKET, BY TYPE     267

12.3.2      MACROECONOMIC OUTLOOK FOR EUROPE      267

12.3.3      GERMANY           272

12.3.3.1  Rising consumer demand for capsule-based pharma and nutraceutical formulations to aid market growth             272

12.3.4      UK          275

12.3.4.1  High demand for nutraceuticals and rapid shift toward plant-based lifestyles to augment market growth       275

12.3.5      FRANCE                279

12.3.5.1  Popularity of self-care trends and regulatory push for plant-based capsules to propel market growth      279

12.3.6      ITALY    282

12.3.6.1  High R&D spending in pharmaceutical manufacturing industry to support market growth    282

12.3.7      SPAIN    286

12.3.7.1  Low production costs and consolidation of biotechnology sector to fuel market growth           286

12.3.8      NETHERLANDS 289

12.3.8.1  Expanding clinical research activity and strong nutraceutical innovation ecosystem to drive market               289

12.3.9      REST OF EUROPE             292

12.4         ASIA PACIFIC     295

12.4.1      ASIA PACIFIC EMPTY CAPSULES VOLUME MARKET, BY TYPE     296

12.4.2      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 297

12.4.3      CHINA  301

12.4.3.1  Rapidly growing pharmaceutical, cosmetic, and nutraceutical industries to augment market growth                301

12.4.4      INDIA    305

12.4.4.1  Surge in demand for dietary supplements and presence of highly skilled medical professionals to favor market growth      305

12.4.5      JAPAN   308

12.4.5.1  Increased demand for high-quality generic oral drugs to boost market demand     308

12.4.6      SOUTH KOREA  312

12.4.6.1  Increased government focus on domestic drug production and R&D to support market growth          312

12.4.7      AUSTRALIA         315

12.4.7.1  Rising incidence of chronic diseases among geriatric population and increasing demand for supplements to fuel market growth   315

12.4.8      NEW ZEALAND 318

12.4.8.1  Increasing prevalence of lifestyle-related disorders and expanding therapeutic supplement use to propel market growth 318

12.4.9      REST OF ASIA PACIFIC   322

12.5         LATIN AMERICA                325

12.5.1      LATIN AMERICAN EMPTY CAPSULES VOLUME MARKET, BY TYPE               325

12.5.2      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 326

12.5.3      BRAZIL 330

12.5.3.1  High export of generics to support market growth          330

12.5.4      MEXICO                333

12.5.4.1  Well-developed healthcare regulatory environment and increased demand for chronic disease treatment to favor market growth     333

12.5.5      REST OF LATIN AMERICA             336

12.6         MIDDLE EAST   339

12.6.1      MIDDLE EASTERN EMPTY CAPSULES VOLUME MARKET, BY TYPE               339

12.6.2      MACROECONOMIC OUTLOOK FOR MIDDLE EAST                 340

12.6.3      GCC COUNTRIES              344

12.6.3.1  Saudi Arabia          348

12.6.3.1.1                Favorable government-led healthcare reforms and increased pharmaceutical production capabilities to aid market growth                 348

12.6.3.2  UAE        351

12.6.3.2.1                Favorable government strategies and high per capita health expenditure to fuel market growth         351

12.6.3.3  Rest of GCC Countries        354

12.6.4      REST OF MIDDLE EAST 357

12.7         AFRICA 360

12.7.1      DEVELOPMENT OF PHARMACEUTICAL SECTOR TO SPUR MARKET GROWTH               360

12.7.2      AFRICAN EMPTY CAPSULES VOLUME MARKET, BY TYPE                 360

12.7.3      MACROECONOMIC OUTLOOK FOR AFRICA        361

13            COMPETITIVE LANDSCAPE         365

13.1         INTRODUCTION              365

13.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            365

13.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EMPTY CAPSULES MARKET, JANUARY 2022–JULY 2025                 365

13.3         REVENUE ANALYSIS, 2020–2024  366

13.4         MARKET SHARE ANALYSIS, 2024                 367

13.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 369

13.5.1      STARS   369

13.5.2      EMERGING LEADERS     370

13.5.3      PERVASIVE PLAYERS      370

13.5.4      PARTICIPANTS 370

13.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         372

13.5.5.1  Company footprint               372

13.5.5.2  Region footprint   373

13.5.5.3  Type footprint       374

13.5.5.4  Functionality footprint         375

13.5.5.5  End-user footprint                376

13.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        377

13.6.1      PROGRESSIVE COMPANIES         377

13.6.2      RESPONSIVE COMPANIES            377

13.6.3      DYNAMIC COMPANIES  377

13.6.4      STARTING BLOCKS         378

13.6.5      COMPETITIVE BENCHMARKING               379

13.6.5.1  Detailed list of key startups/SMEs    379

13.6.5.2  Competitive benchmarking of startups/SMEs 380

13.7         COMPANY VALUATION & FINANCIAL METRICS 381

13.7.1      FINANCIAL METRICS      381

13.7.2      COMPANY VALUATION 381

13.8         BRAND/PRODUCT COMPARISON             382

13.9         COMPETITIVE SCENARIO             383

13.9.1      PRODUCT LAUNCHES & APPROVALS     383

13.9.2      DEALS  384

13.9.3      EXPANSIONS     385

13.9.4      OTHER DEVELOPMENTS              386

14            COMPANY PROFILES      387

14.1         KEY PLAYERS     387

14.1.1      CAPSUGEL (LONZA)       387

14.1.1.1  Business overview 387

14.1.1.2  Products offered   388

14.1.1.3  Recent developments           390

14.1.1.3.1                Product launches  390

14.1.1.3.2                Other developments             391

14.1.1.4  MnM view              391

14.1.1.4.1                Key strengths        391

14.1.1.4.2                Strategic choices   391

14.1.1.4.3                Weaknesses & competitive threats     391

14.1.2      ACG       392

14.1.2.1  Business overview 392

14.1.2.2  Products offered   393

14.1.2.3  Recent developments           394

14.1.2.3.1                Expansions             394

14.1.2.3.2                Other developments             394

14.1.2.4  MnM view              395

14.1.2.4.1                Key strengths        395

14.1.2.4.2                Strategic choices   395

14.1.2.4.3                Weaknesses & competitive threats     395

14.1.3      QUALICAPS (ROQUETTE FRÈRES)            396

14.1.3.1  Business overview 396

14.1.3.2  Products offered   397

14.1.3.3  Recent developments           398

14.1.3.3.1                Deals      398

14.1.3.3.2                Expansions             399

14.1.3.4  MnM view              399

14.1.3.4.1                Key strengths        399

14.1.3.4.2                Strategic choices   399

14.1.3.4.3                Weaknesses & competitive threats     399

14.1.4      SUHEUNG           400

14.1.4.1  Business overview 400

14.1.4.2  Products offered   401

14.1.4.3  Recent developments           402

14.1.4.3.1                Product launches & approvals            402

14.1.5      HEALTHCAPS INDIA       404

14.1.5.1  Business overview 404

14.1.5.2  Products offered   405

14.1.6      NECTAR LIFESCIENCES LTD.      406

14.1.6.1  Business overview 406

14.1.6.2  Products offered   407

14.1.6.3  Recent developments           407

14.1.6.3.1                Deals      407

14.1.7      SUNIL HEALTHCARE LIMITED   408

14.1.7.1  Business overview 408

14.1.7.2  Products offered   409

14.1.8      NATURAL CAPSULES LIMITED  411

14.1.8.1  Business overview 411

14.1.8.2  Products offered   412

14.1.8.3  Recent developments           413

14.1.8.3.1                Deals      413

14.1.9      QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.)         414

14.1.9.1  Business overview 414

14.1.9.2  Products offered   415

14.1.9.3  Recent developments           415

14.1.9.3.1                Product launches  415

14.1.10   COMED CHEMICALS LIMITED   416

14.1.10.1                 Business overview 416

14.1.10.2                 Products offered   417

14.1.11   ANHUI HUANGSHAN CAPSULE CO., LTD.              418

14.1.11.1                 Business overview 418

14.1.11.2                 Products offered   419

14.1.12   FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED)                 420

14.1.12.1                 Business overview 420

14.1.12.2                 Products offered   421

14.1.12.3                 Recent developments           421

14.1.12.3.1             Deals      421

14.1.13   SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.)              422

14.1.13.1                 Business overview 422

14.1.13.2                 Products offered   423

14.1.14   CAPSCANADA   424

14.1.14.1                 Business overview 424

14.1.14.2                 Products offered   424

14.1.15   FARMACÁPSULAS            426

14.1.15.1                 Business overview 426

14.1.15.2                 Products offered   426

14.1.16   SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.                 428

14.1.16.1                 Business overview 428

14.1.16.2                 Products offered   428

14.1.16.3                 Recent developments           429

14.1.16.3.1             Other developments             429

14.1.17   ERAWAT PHARMA LIMITED        430

14.1.17.1                 Business overview 430

14.1.17.2                 Products offered   430

14.2         OTHER PLAYERS              432

14.2.1      SAVIOURCAPS   432

14.2.2      SHANXI JC BIOLOGICAL TECHNOLOGY CO.        433

14.2.3      ROXLOR               433

14.2.4      MEDISCA INC.   434

14.2.5      ZHEJIANG YUEXI CAPSULE CO., LTD.      435

14.2.6      SHAOXING KANGKE CAPSULE CO., LTD.               436

14.2.7      ZHEJIANG HUILI CAPSULES CO., LTD.    437

14.2.8      SHAOXING ZHONGYA CAPSULE CO., LTD.           438

14.2.9      SHING LIH FANG ENTERPRISE CO., LTD.               439

14.2.10   LEFANCAPS        440

14.2.11   CHEMCAPS LIMITED      441

14.2.12   BIOCAPS ENTERPRISE   441

14.2.13   SNAIL PHARMA INDUSTRY          442

14.2.14   BRIGHT PHARMA CAPS 443

14.2.15   SHREE PHARMA CAPS    444

14.2.16   HEXIN CAPSULE CO., LTD.           445

14.2.17   WUHAN CARMA TECHNOLOGY CO., LTD.            446

14.2.18   AIPAK PHARMA 447

15            APPENDIX           448

15.1         DISCUSSION GUIDE        448

15.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                455

15.3         CUSTOMIZATION OPTIONS        457

15.4         RELATED REPORTS         458

15.5         AUTHOR DETAILS           459

LIST OF TABLES

TABLE 1                EMPTY CAPSULES MARKET: INCLUSIONS & EXCLUSIONS      43

TABLE 2                IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS  55

TABLE 3                EMPTY CAPSULES MARKET: RISK ANALYSIS                 59

TABLE 4                EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 72

TABLE 5                AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE,

2022−2024 (USD)              82

TABLE 6                AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY REGION,

2022−2024 (USD)              83

TABLE 7                EMPTY CAPSULES MARKET: RAW MATERIAL VENDORS            89

TABLE 8                EMPTY CAPSULES MARKET: PRODUCT PROVIDERS        90

TABLE 9                EMPTY CAPSULES MARKET: END USERS                 91

TABLE 10              EMPTY CAPSULES MARKET: REGULATORY AUTHORITIES   91

TABLE 11              EMERGING BUSINESS MODELS AND TARGET SEGMENTS IN EMPTY CAPSULES MARKET           92

TABLE 12              EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES                93

TABLE 13              KEY STAKEHOLDERS ACROSS VARIOUS END-USE INDUSTRIES INFLUENCING BUYING PROCESS          96

TABLE 14              KEY BUYING CRITERIA FOR EMPTY CAPSULES, BY END USER     97

TABLE 15              EMPTY CAPSULES: ADOPTION BARRIER & INTERNAL FRICTION     99

TABLE 16              NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014−2024               99

TABLE 17              TOP 10 PATENT OWNERS/APPLICANTS IN EMPTY CAPSULES MARKET, 2014−2024  101

TABLE 18              INDICATIVE LIST OF PATENTS IN EMPTY CAPSULES MARKET, 2023−2025 101

TABLE 19              EMPTY CAPSULES MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025−DECEMBER 2026                 103

TABLE 20              IMPORT DATA FOR HS CODE 960200, 2020−2024 (USD THOUSAND)           104

TABLE 21              EXPORT DATA FOR HS CODE 960200, 2020−2024 (USD THOUSAND)           105

TABLE 22              IMPORT VOLUME FOR HS CODE 960200, 2020–2024 (TONS)       106

TABLE 23              EXPORT VOLUME FOR HS CODE 960200, 2020–2024 (TONS)       107

TABLE 24              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 110

TABLE 25              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           111

TABLE 26              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 113

TABLE 27              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  114

TABLE 28              STARTEGIC ANALYSIS OF GROWTH OPPORTUNITIES IN EMPTY CAPSULES MARKET                117

TABLE 29              KEY COMPANIES IMPLEMENTING AI IN EMPTY CAPSULES MARKET        121

TABLE 30              EMPTY CAPSULES-RELATED TARIFF REVISION                 123

TABLE 31              KEY PLAYERS AND THEIR INSTALLED ANNUAL PRODUCTION CAPACITY IN EMPTY CAPSULES MARKET                 129

TABLE 32              EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 132

TABLE 33              EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS)              132

TABLE 34              GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)          133

TABLE 35              NORTH AMERICA: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            134

TABLE 36              EUROPE: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            134

TABLE 37              ASIA PACIFIC: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            135

TABLE 38              LATIN AMERICA: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            135

TABLE 39              MIDDLE EAST: GELATIN EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            136

TABLE 40              GCC COUNTRIES: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            136

TABLE 41              GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (BILLION UNITS)      137

TABLE 42              NON-GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)          138

TABLE 43              NORTH AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            138

TABLE 44              EUROPE: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            139

TABLE 45              ASIA PACIFIC: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            139

TABLE 46              LATIN AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            140

TABLE 47              MIDDLE EAST: NON-GELATIN EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            140

TABLE 48              GCC COUNTRIES: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            140

TABLE 49              NON-GELATIN EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (BILLION UNITS)         141

TABLE 50              GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            143

TABLE 51              PORCINE GELATIN CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)          144

TABLE 52              NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            144

TABLE 53              EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            145

TABLE 54              ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            145

TABLE 55              LATIN AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            146

TABLE 56              MIDDLE EAST: PORCINE GELATIN CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            146

TABLE 57              GCC COUNTRIES: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            146

TABLE 58             BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            147

TABLE 59              NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               148

TABLE 60              EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            148

TABLE 61              ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            149

TABLE 62              LATIN AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 149

TABLE 63              MIDDLE EAST: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            150

TABLE 64              GCC COUNTRIES: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 150

TABLE 65              BONEMEAL GELATIN CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)          151

TABLE 66              NORTH AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            151

TABLE 67              EUROPE: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            152

TABLE 68              ASIA PACIFIC: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            152

TABLE 69              LATIN AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 70              MIDDLE EAST: BONEMEAL GELATIN CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            153

TABLE 71              GCC COUNTRIES: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 72              OTHER GELATIN SOURCES MARKET, BY REGION, 2023–2030 (USD MILLION)          154

TABLE 73              NORTH AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            154

TABLE 74              EUROPE: OTHER GELATIN SOURCES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            155

TABLE 75              ASIA PACIFIC: OTHER GELATIN SOURCES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            155

TABLE 76              LATIN AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            156

TABLE 77              MIDDLE EAST: OTHER GELATIN SOURCES MARKET, BY REGION,

2023–2030 (USD MILLION)            156

TABLE 78              GCC COUNTRIES: OTHER GELATIN CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            156

TABLE 79              NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            157

TABLE 80              HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY REGION,

2023–2030 (USD MILLION)            158

TABLE 81              NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               158

TABLE 82              EUROPE: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               159

TABLE 83              ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               159

TABLE 84              LATIN AMERICA: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               160

TABLE 85              MIDDLE EAST: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET,

BY REGION, 2023–2030 (USD MILLION)   160

TABLE 86              GCC COUNTRIES: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               160

TABLE 87              PULLULAN & STARCH MARKET, BY REGION, 2023–2030 (USD MILLION)            161

TABLE 88              NORTH AMERICA: PULLULAN & STARCH MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            162

TABLE 89              EUROPE: PULLULAN & STARCH MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            162

TABLE 90              ASIA PACIFIC: PULLULAN & STARCH MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            163

TABLE 91              LATIN AMERICA: PULLULAN & STARCH MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            163

TABLE 92              MIDDLE EAST: PULLULAN & STARCH MARKET, BY REGION,

2023–2030 (USD MILLION)            163

TABLE 93              GCC COUNTRIES: PULLULAN & STARCH MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            164

TABLE 94              EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION)       166

TABLE 95              IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            167

TABLE 96              NORTH AMERICA: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               167

TABLE 97              EUROPE: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            168

TABLE 98              ASIA PACIFIC: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 168

TABLE 99              LATIN AMERICA: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 169

TABLE 100            MIDDLE EAST: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)                 169

TABLE 101            GCC COUNTRIES: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               169

TABLE 102            SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            170

TABLE 103            NORTH AMERICA: SUSTAINED-RELEASE EMPTY CAPSULES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               171

TABLE 104            EUROPE: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            171

TABLE 105            ASIA PACIFIC: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 172

TABLE 106            LATIN AMERICA: SUSTAINED-RELEASE EMPTY CAPSULES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               172

TABLE 107            MIDDLE EAST: SUSTAINED-RELEASE EMPTY CAPSULES MARKET,

BY REGION, 2023–2030 (USD MILLION)   173

TABLE 108            GCC COUNTRIES: SUSTAINED-RELEASE EMPTY CAPSULES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               173

TABLE 109            DELAYED-RELEASE EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            174

TABLE 110            NORTH AMERICA: DELAYED-RELEASE EMPTY CAPSULES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               174

TABLE 111            EUROPE: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            175

TABLE 112            ASIA PACIFIC: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            175

TABLE 113            LATIN AMERICA: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 176

TABLE 114            MIDDLE EAST: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            176

TABLE 115            GCC COUNTRIES: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 176

TABLE 116            EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 178

TABLE 117            SIZE 0 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)            179

TABLE 118            NORTH AMERICA: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            179

TABLE 119            EUROPE: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            180

TABLE 120          ASIA PACIFIC: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            180

TABLE 121            LATIN AMERICA: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            181

TABLE 122            MIDDLE EAST: SIZE 0 EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            181

TABLE 123            GCC COUNTRIES: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            181

TABLE 124            SIZE 00 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)            182

TABLE 125            NORTH AMERICA: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            183

TABLE 126            EUROPE: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            183

TABLE 127            ASIA PACIFIC: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            184

TABLE 128            LATIN AMERICA: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            184

TABLE 129            MIDDLE EAST: SIZE 00 EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            185

TABLE 130            GCC COUNTRIES: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            185

TABLE 131            SIZE 1 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)            186

TABLE 132            NORTH AMERICA: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            186

TABLE 133            EUROPE: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            187

TABLE 134          ASIA PACIFIC: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            187

TABLE 135            LATIN AMERICA: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            188

TABLE 136            MIDDLE EAST: SIZE 1 EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            188

TABLE 137            GCC COUNTRIES: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            188

TABLE 138            SIZE 2 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)            189

TABLE 139            NORTH AMERICA: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            190

TABLE 140            EUROPE: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            190

TABLE 141          ASIA PACIFIC: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            191

TABLE 142            LATIN AMERICA: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            191

TABLE 143            MIDDLE EAST: SIZE 2 EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            192

TABLE 144            GCC COUNTRIES: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            192

TABLE 145          SIZE 000 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)            193

TABLE 146            NORTH AMERICA: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            193

TABLE 147            EUROPE: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            194

TABLE 148            ASIA PACIFIC: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            194

TABLE 149            LATIN AMERICA: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            195

TABLE 150            MIDDLE EAST: SIZE 000 EMPTY CAPSULES MARKET, BY REGION

2023–2030 (USD MILLION)            195

TABLE 151            GCC COUNTRIES: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            195

TABLE 152            SIZE 3 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)            196

TABLE 153            NORTH AMERICA: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            196

TABLE 154            EUROPE: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            197

TABLE 155          ASIA PACIFIC: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            197

TABLE 156            LATIN AMERICA: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            198

TABLE 157            MIDDLE EAST: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            198

TABLE 158            GCC COUNTRIES: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            198

TABLE 159            SIZE 4 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)            199

TABLE 160            NORTH AMERICA: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            199

TABLE 161            EUROPE: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            200

TABLE 162          ASIA PACIFIC: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            200

TABLE 163            LATIN AMERICA: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            201

TABLE 164            MIDDLE EAST: SIZE 4 EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            201

TABLE 165            GCC COUNTRIES: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            201

TABLE 166            SIZE 5 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)            202

TABLE 167            NORTH AMERICA: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            202

TABLE 168            EUROPE: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            203

TABLE 169          ASIA PACIFIC: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            203

TABLE 170            LATIN AMERICA: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            204

TABLE 171            MIDDLE EAST: SIZE 5 EMPTY Y CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            204

TABLE 172            GCC COUNTRIES: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            204

TABLE 173            EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            206

TABLE 174            EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS,

BY REGION, 2023–2030 (USD MILLION)   207

TABLE 175            NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023–2030 (USD MILLION)            207

TABLE 176            EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023–2030 (USD MILLION)       208

TABLE 177            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023–2030 (USD MILLION)       208

TABLE 178            LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023–2030 (USD MILLION)            209

TABLE 179            MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY REGION, 2023–2030 (USD MILLION) 209

TABLE 180            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023–2030 (USD MILLION)            209

TABLE 181            EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION,

2023–2030 (USD MILLION)            210

TABLE 182            NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               211

TABLE 183            EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION)            211

TABLE 184            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 185            LATIN AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 186            MIDDLE EAST: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS,

BY REGION, 2023–2030 (USD MILLION)   213

TABLE 187            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               213

TABLE 188            EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS,

BY REGION, 2023–2030 (USD MILLION)   214

TABLE 189            NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     214

TABLE 190            EUROPE: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            215

TABLE 191            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            215

TABLE 192            LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     216

TABLE 193            MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY REGION, 2023–2030 (USD MILLION)            216

TABLE 194            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     216

TABLE 195            EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION,

2023–2030 (USD MILLION)            217

TABLE 196            NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 217

TABLE 197            EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               218

TABLE 198            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               218

TABLE 199            LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               219

TABLE 200            MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS,

BY REGION, 2023–2030 (USD MILLION)   219

TABLE 201            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               219

TABLE 202            EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION,

2023–2030 (USD MILLION)            220

TABLE 203            NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 221

TABLE 204            EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS,

BY COUNTRY, 2023–2030 (USD MILLION)               221

TABLE 205            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS,

BY COUNTRY, 2023–2030 (USD MILLION)               222

TABLE 206            LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS,

BY COUNTRY, 2023–2030 (USD MILLION)               222

TABLE 207            MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS,

BY REGION, 2023–2030 (USD MILLION)   223

TABLE 208            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 223

TABLE 209            EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2023–2030 (USD MILLION) 224

TABLE 210            NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION)       224

TABLE 211            EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS,

BY COUNTRY, 2023–2030 (USD MILLION)               225

TABLE 212            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 225

TABLE 213            LATIN AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION)       226

TABLE 214            MIDDLE EAST: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2023–2030 (USD MILLION) 226

TABLE 215            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION)       226

TABLE 216            EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY REGION,

2023–2030 (USD MILLION)            227

TABLE 217            NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS,

BY COUNTRY, 2023–2030 (USD MILLION)               228

TABLE 218            EUROPE: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023–2030 (USD MILLION)            228

TABLE 219            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS,

BY COUNTRY, 2023–2030 (USD MILLION)               229

TABLE 220            LATIN AMERICA: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS,

BY COUNTRY, 2023–2030 (USD MILLION)               229

TABLE 221            MIDDLE EAST: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS,

BY REGION, 2023–2030 (USD MILLION)   230

TABLE 222            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS,

BY COUNTRY, 2023–2030 (USD MILLION)               230

TABLE 223            EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)            231

TABLE 224            NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       231

TABLE 225            EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               232

TABLE 226            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 232

TABLE 227            LATIN AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       233

TABLE 228            MIDDLE EAST: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 233

TABLE 229            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       233

TABLE 230            EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)       235

TABLE 231            EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION,

2023–2030 (USD MILLION)            236

TABLE 232            NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 236

TABLE 233            EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               237

TABLE 234            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               237

TABLE 235            LATIN AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)             238

TABLE 236            MIDDLE EAST: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY,

BY REGION, 2023–2030 (USD MILLION)   238

TABLE 237            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 238

TABLE 238            EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION,

2023–2030 (USD MILLION)            240

TABLE 239            NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               240

TABLE 240            EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               241

TABLE 241            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               241

TABLE 242            LATIN AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               242

TABLE 243            MIDDLE EAST: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY,

BY REGION, 2023–2030 (USD MILLION)   242

TABLE 244            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               242

TABLE 245            EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY REGION,

2023–2030 (USD MILLION)            243

TABLE 246            NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               244

TABLE 247            EUROPE: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION)                 244

TABLE 248            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               245

TABLE 249            LATIN AMERICA: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               245

TABLE 250            MIDDLE EAST: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY REGION, 2023–2030 (USD MILLION)                 246

TABLE 251            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               246

TABLE 252            EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION,

2023–2030 (USD MILLION)            247

TABLE 253            NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES,

BY COUNTRY, 2023–2030 (USD MILLION)               247

TABLE 254            EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES,

BY COUNTRY, 2023–2030 (USD MILLION)               248

TABLE 255            ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES,

BY COUNTRY, 2023–2030 (USD MILLION)               248

TABLE 256            LATIN AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES,

BY COUNTRY, 2023–2030 (USD MILLION)               249

TABLE 257            MIDDLE EAST: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES,

BY REGION, 2023–2030 (USD MILLION)   249

TABLE 258            GCC COUNTRIES: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES,

BY COUNTRY, 2023–2030 (USD MILLION)               249

TABLE 259            EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION)       251

TABLE 260            EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (BILLION UNITS)   252

TABLE 261            NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE,

2023–2030 (BILLION UNITS)         254

TABLE 262            NORTH AMERICA: KEY MACROINDICATORS                 255

TABLE 263            NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            255

TABLE 264            NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE,

2023–2030 (USD MILLION)            255

TABLE 265            NORTH AMERICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            256

TABLE 266            NORTH AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            256

TABLE 267            NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            256

TABLE 268            NORTH AMERICA: EMPTY CAPSULES MARKET, BY SIZE,

2023–2030 (USD MILLION)            257

TABLE 269            NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)                 257

TABLE 270            NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            258

TABLE 271            US: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)       259

TABLE 272            US: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            259

TABLE 273            US: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            260

TABLE 274            US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION)       260

TABLE 275            US: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)       261

TABLE 276            US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            261

TABLE 277            US: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)            262

TABLE 278            CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            263

TABLE 279            CANADA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            263

TABLE 280            CANADA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            263

TABLE 281            CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            264

TABLE 282            CANADA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            264

TABLE 283            CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            265

TABLE 284            CANADA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                265

TABLE 285            COMPARATIVE ANALYSIS OF GENERIC PENETRATION AMONG EUROPEAN COUNTRIES, BY VOLUME, 2025        266

TABLE 286            EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS)         267

TABLE 287            EUROPE: KEY MACROINDICATORS          268

TABLE 288            EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     268

TABLE 289            EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            269

TABLE 290            EUROPE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            269

TABLE 291            EUROPE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            269

TABLE 292            EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            270

TABLE 293            EUROPE: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            270

TABLE 294            EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            271

TABLE 295            EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                271

TABLE 296          GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            272

TABLE 297            GERMANY: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            273

TABLE 298            GERMANY: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            273

TABLE 299            GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            273

TABLE 300            GERMANY: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            274

TABLE 301            GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            274

TABLE 302            GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                275

TABLE 303            UK: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)       276

TABLE 304            UK: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            276

TABLE 305            UK: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            276

TABLE 306            UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION)       277

TABLE 307            UK: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)       277

TABLE 308            UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            278

TABLE 309            UK: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)            278

TABLE 310            FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            279

TABLE 311            FRANCE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            279

TABLE 312            FRANCE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            280

TABLE 313            FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            280

TABLE 314            FRANCE: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            281

TABLE 315            FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            281

TABLE 316            FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                282

TABLE 317            ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            283

TABLE 318            ITALY: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            283

TABLE 319            ITALY: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            283

TABLE 320            ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION)       284

TABLE 321            ITALY: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            284

TABLE 322            ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            285

TABLE 323            ITALY: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                285

TABLE 324            SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            286

TABLE 325            SPAIN: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            286

TABLE 326            SPAIN: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            287

TABLE 327            SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            287

TABLE 328            SPAIN: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            288

TABLE 329            SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            288

TABLE 330            SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                289

TABLE 331            NETHERLANDS: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)                289

TABLE 332            NETHERLANDS: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            290

TABLE 333            NETHERLANDS: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            290

TABLE 334            NETHERLANDS: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            290

TABLE 335            NETHERLANDS: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 291

TABLE 336            NETHERLANDS: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)                 291

TABLE 337            NETHERLANDS: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            292

TABLE 338            REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE,

2023–2030 (USD MILLION)            292

TABLE 339            REST OF EUROPE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            293

TABLE 340            REST OF EUROPE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            293

TABLE 341            REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            293

TABLE 342            REST OF EUROPE: EMPTY CAPSULES MARKET, BY SIZE,

2023–2030 (USD MILLION)            294

TABLE 343            REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)                 294

TABLE 344            REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            295

TABLE 345            ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS)            297

TABLE 346            ASIA PACIFIC: KEY MACROINDICATORS                 297

TABLE 347            ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            298

TABLE 348            ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)                298

TABLE 349            ASIA PACIFIC: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            299

TABLE 350            ASIA PACIFIC: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)                 299

TABLE 351            ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            299

TABLE 352            ASIA PACIFIC: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 300

TABLE 353            ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            300

TABLE 354            ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            301

TABLE 355            CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            302

TABLE 356            CHINA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            302

TABLE 357            CHINA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            302

TABLE 358            CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            303

TABLE 359            CHINA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            303

TABLE 360            CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            304

TABLE 361            CHINA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                304

TABLE 362            INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            305

TABLE 363            INDIA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            306

TABLE 364            INDIA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            306

TABLE 365            INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            306

TABLE 366            INDIA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            307

TABLE 367            INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            307

TABLE 368            INDIA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                308

TABLE 369            JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            309

TABLE 370            JAPAN: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            309

TABLE 371            JAPAN: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            309

TABLE 372            JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            310

TABLE 373            JAPAN: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            310

TABLE 374            JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            311

TABLE 375            JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                311

TABLE 376            SOUTH KOREA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)                312

TABLE 377            SOUTH KOREA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            312

TABLE 378            SOUTH KOREA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            313

TABLE 379            SOUTH KOREA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            313

TABLE 380            SOUTH KOREA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 314

TABLE 381            SOUTH KOREA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)                 314

TABLE 382            SOUTH KOREA: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            315

TABLE 383            AUSTRALIA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)                315

TABLE 384            AUSTRALIA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            316

TABLE 385            AUSTRALIA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            316

TABLE 386            AUSTRALIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            316

TABLE 387            AUSTRALIA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 317

TABLE 388            AUSTRALIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            317

TABLE 389            AUSTRALIA: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            318

TABLE 390            NEW ZEALAND: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)                319

TABLE 391            NEW ZEALAND: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            319

TABLE 392            NEW ZEALAND: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            319

TABLE 393            NEW ZEALAND: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            320

TABLE 394            NEW ZEALAND: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 320

TABLE 395            NEW ZEALAND: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)                 321

TABLE 396            NEW ZEALAND: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            321

TABLE 397            REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE,

2023–2030 (USD MILLION)            322

TABLE 398            REST OF ASIA PACIFIC: GELATIN EMPTY CAPSULES MARKET,

BY RAW MATERIAL, 2023–2030 (USD MILLION)   323

TABLE 399            REST OF ASIA PACIFIC: NON-GELATIN EMPTY CAPSULES MARKET,

BY RAW MATERIAL, 2023–2030 (USD MILLION)   323

TABLE 400            REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            323

TABLE 401            REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY SIZE,

2023–2030 (USD MILLION)            324

TABLE 402            REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)            324

TABLE 403            REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            325

TABLE 404            LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE,

2023–2030 (BILLION UNITS)         326

TABLE 405            LATIN AMERICA: KEY MACROINDICATORS                 326

TABLE 406            LATIN AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            327

TABLE 407            LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)         327

TABLE 408            LATIN AMERICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            327

TABLE 409            LATIN AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            328

TABLE 410            LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            328

TABLE 411            LATIN AMERICA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)           329

TABLE 412            LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)                 329

TABLE 413            LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            330

TABLE 414            BRAZIL: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            330

TABLE 415            BRAZIL: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            331

TABLE 416            BRAZIL: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            331

TABLE 417            BRAZIL: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            331

TABLE 418            BRAZIL: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            332

TABLE 419            BRAZIL: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            332

TABLE 420            BRAZIL: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                333

TABLE 421            MEXICO: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            333

TABLE 422            MEXICO: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            334

TABLE 423            MEXICO: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            334

TABLE 424            MEXICO: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            334

TABLE 425            MEXICO: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            335

TABLE 426            MEXICO: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            335

TABLE 427            MEXICO: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                336

TABLE 428            REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE,

2023–2030 (USD MILLION)            336

TABLE 429            REST OF LATIN AMERICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            337

TABLE 430            REST OF LATIN AMERICA: NON-GELATIN EMPTY CAPSULES MARKET,

BY RAW MATERIAL, 2023–2030 (USD MILLION)   337

TABLE 431            REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            337

TABLE 432            REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY SIZE,

2023–2030 (USD MILLION)            338

TABLE 433            REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)            338

TABLE 434            REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            339

TABLE 435            MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS)            340

TABLE 436            MIDDLE EAST: KEY MACROINDICATORS                 341

TABLE 437            MIDDLE EAST: EMPTY CAPSULES MARKET, BY REGION,

2023–2030 (USD MILLION)            341

TABLE 438            MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)                341

TABLE 439            MIDDLE EAST: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            342

TABLE 440            MIDDLE EAST: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            342

TABLE 441            MIDDLE EAST: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            342

TABLE 442            MIDDLE EAST: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 343

TABLE 443            MIDDLE EAST: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            343

TABLE 444            MIDDLE EAST: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            344

TABLE 445            GCC COUNTRIES: EMPTY CAPSULES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            344

TABLE 446            GCC COUNTRIES: EMPTY CAPSULES MARKET, BY TYPE,

2023–2030 (USD MILLION)            345

TABLE 447            GCC COUNTRIES: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            345

TABLE 448            GCC COUNTRIES: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            345

TABLE 449            GCC COUNTRIES: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            346

TABLE 450            GCC COUNTRIES: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)           346

TABLE 451            GCC COUNTRIES: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)                 347

TABLE 452            GCC COUNTRIES: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            347

TABLE 453            SAUDI ARABIA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)                348

TABLE 454            SAUDI ARABIA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            348

TABLE 455            SAUDI ARABIA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            349

TABLE 456            SAUDI ARABIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            349

TABLE 457            SAUDI ARABIA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 350

TABLE 458            SAUDI ARABIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            350

TABLE 459            SAUDI ARABIA: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            351

TABLE 460            UAE: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)       351

TABLE 461            UAE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            352

TABLE 462          UAE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            352

TABLE 463            UAE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION)       352

TABLE 464            UAE: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)       353

TABLE 465            UAE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            353

TABLE 466            UAE: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)            354

TABLE 467            REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY TYPE,

2023–2030 (USD MILLION)            354

TABLE 468            REST OF GCC COUNTRIES: GELATIN EMPTY CAPSULES MARKET,

BY RAW MATERIAL, 2023–2030 (USD MILLION)   355

TABLE 469            REST OF GCC COUNTRIES: NON-GELATIN EMPTY CAPSULES MARKET,

BY RAW MATERIAL, 2023–2030 (USD MILLION)   355

TABLE 470            REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            355

TABLE 471            REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY SIZE,

2023–2030 (USD MILLION)            356

TABLE 472            REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)            356

TABLE 473            REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            357

TABLE 474            REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE,

2023–2030 (USD MILLION)            357

TABLE 475            REST OF MIDDLE EAST: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION)            358

TABLE 476            REST OF MIDDLE EAST: NON-GELATIN EMPTY CAPSULES MARKET,

BY RAW MATERIAL, 2023–2030 (USD MILLION)   358

TABLE 477            REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            358

TABLE 478            REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY SIZE,

2023–2030 (USD MILLION)            359

TABLE 479            REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION)            359

TABLE 480            REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY END USER,

2023–2030 (USD MILLION)            360

TABLE 481            AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS)         361

TABLE 482            AFRICA: KEY MACROINDICATORS            361

TABLE 483            AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION)            362

TABLE 484            AFRICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            362

TABLE 485            AFRICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL,

2023–2030 (USD MILLION)            362

TABLE 486            AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            363

TABLE 487            AFRICA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION)            363

TABLE 488            AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2023–2030 (USD MILLION)            364

TABLE 489            AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION)                364

TABLE 490            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN EMPTY CAPSULES MARKET, JANUARY 2022–JULY 2025        365

TABLE 491            EMPTY CAPSULES MARKET: DEGREE OF COMPETITION 368

TABLE 492            EMPTY CAPSULES MARKET: REGION FOOTPRINT       373

TABLE 493            EMPTY CAPSULES MARKET: TYPE FOOTPRINT                 374

TABLE 494            EMPTY CAPSULES MARKET: FUNCTIONALITY FOOTPRINT       375

TABLE 495            EMPTY CAPSULES MARKET: END-USER FOOTPRINT       376

TABLE 496            EMPTY CAPSULES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS    379

TABLE 497            EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY TYPE AND REGION                380

TABLE 498            EMPTY CAPSULES MARKET: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–JULY 2025               383

TABLE 499            EMPTY CAPSULES MARKET: DEALS, JANUARY 2022–JULY 2025  384

TABLE 500            EMPTY CAPSULES MARKET: EXPANSIONS, JANUARY 2022–JULY 2025               385

TABLE 501            EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025          386

TABLE 502            CAPSUGEL (LONZA): COMPANY OVERVIEW                 387

TABLE 503            CAPSUGEL (LONZA): PRODUCTS OFFERED                 388

TABLE 504            CAPSUGEL (LONZA): PRODUCT LAUNCHES, JANUARY 2022–JULY 2025               390

TABLE 505            CAPSUGEL (LONZA): OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025               391

TABLE 506            ACG: COMPANY OVERVIEW        392

TABLE 507            ACG: PRODUCTS OFFERED         393

TABLE 508            ACG: EXPANSIONS, JANUARY 2022–JULY 2025                 394

TABLE 509            ACG: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025             394

TABLE 510            QUALICAPS (ROQUETTE FRÈRES): COMPANY OVERVIEW          396

TABLE 511            QUALICAPS (ROQUETTE FRÈRES): PRODUCTS OFFERED             397

TABLE 512            QUALICAPS (ROQUETTE FRÈRES): DEALS, JANUARY 2022–JULY 2025               398

TABLE 513          QUALICAPS (ROQUETTE FRÈRES): EXPANSIONS, JANUARY 2022–JULY 2025               399

TABLE 514            SUHEUNG: COMPANY OVERVIEW            400

TABLE 515            SUHEUNG: PRODUCTS OFFERED             401

TABLE 516          SUHEUNG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025               402

TABLE 517            HEALTHCAPS INDIA: COMPANY OVERVIEW                 404

TABLE 518            HEALTHCAPS INDIA: PRODUCTS OFFERED                 405

TABLE 519            NECTAR LIFESCIENCES LTD.: COMPANY OVERVIEW          406

TABLE 520            NECTAR LIFESCIENCES LTD.: PRODUCTS OFFERED             407

TABLE 521            NECTAR LIFESCIENCES LTD.: DEALS, JANUARY 2022–JULY 2025  407

TABLE 522            SUNIL HEALTHCARE LIMITED: COMPANY OVERVIEW          408

TABLE 523            SUNIL HEALTHCARE LIMITED: PRODUCTS OFFERED             409

TABLE 524            NATURAL CAPSULES LIMITED: COMPANY OVERVIEW          411

TABLE 525            NATURAL CAPSULES LIMITED: PRODUCTS OFFERED             412

TABLE 526            NATURAL CAPSULES LIMITED: DEALS, JANUARY 2022–JULY 2025               413

TABLE 527            QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): COMPANY OVERVIEW          414

TABLE 528            QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCTS OFFERED             415

TABLE 529            QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCT LAUNCHES, JANUARY 2022–JULY 2025     415

TABLE 530            COMED CHEMICALS LIMITED: COMPANY OVERVIEW          416

TABLE 531            COMED CHEMICALS LIMITED: PRODUCTS OFFERED             417

TABLE 532            ANHUI HUANGSHAN CAPSULE CO., LTD.: COMPANY OVERVIEW   418

TABLE 533            ANHUI HUANGSHAN CAPSULE CO., LTD.: PRODUCTS OFFERED    419

TABLE 534            FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): COMPANY OVERVIEW             420

TABLE 535            FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): PRODUCTS OFFERED              421

TABLE 536            FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): DEALS,

JANUARY 2022–JULY 2025               421

TABLE 537            SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.): COMPANY OVERVIEW                 422

TABLE 538            SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.): PRODUCTS OFFERED                 423

TABLE 539            CAPSCANADA: COMPANY OVERVIEW    424

TABLE 540            CAPSCANADA: PRODUCTS OFFERED     424

TABLE 541            FARMACÁPSULAS: COMPANY OVERVIEW                 426

TABLE 542            FARMACÁPSULAS: PRODUCTS OFFERED                 426

TABLE 543            SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.: COMPANY OVERVIEW              428

TABLE 544            SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.: PRODUCTS OFFERED               428

TABLE 545            SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025                 429

TABLE 546            ERAWAT PHARMA LIMITED: COMPANY OVERVIEW          430

TABLE 547            ERAWAT PHARMA LIMITED: PRODUCTS OFFERED             430

TABLE 548            SAVIOURCAPS: COMPANY OVERVIEW   432

TABLE 549            SHANXI JC BIOLOGICAL TECHNOLOGY CO.: COMPANY OVERVIEW   433

TABLE 550            ROXLOR: COMPANY OVERVIEW                433

TABLE 551            MEDISCA INC.: COMPANY OVERVIEW    434

TABLE 552            ZHEJIANG YUEXI CAPSULE CO., LTD.: COMPANY OVERVIEW          435

TABLE 553            SHAOXING KANGKE CAPSULE CO., LTD.: COMPANY OVERVIEW   436

TABLE 554            ZHEJIANG HUILI CAPSULES CO., LTD.: COMPANY OVERVIEW   437

TABLE 555            SHAOXING ZHONGYA CAPSULE CO., LTD.: COMPANY OVERVIEW   438

TABLE 556            SHING LIH FANG ENTERPRISE CO., LTD.: COMPANY OVERVIEW   439

TABLE 557            LEFANCAPS: COMPANY OVERVIEW         440

TABLE 558            CHEMCAPS LIMITED: COMPANY OVERVIEW                 441

TABLE 559            BIOCAPS ENTERPRISE: COMPANY OVERVIEW                 441

TABLE 560            SNAIL PHARMA INDUSTRY: COMPANY OVERVIEW          442

TABLE 561            BRIGHT PHARMA CAPS: COMPANY OVERVIEW                 443

TABLE 562            SHREE PHARMA CAPS: COMPANY OVERVIEW                 444

TABLE 563            HEXIN CAPSULE CO., LTD.: COMPANY OVERVIEW          445

TABLE 564            WUHAN CARMA TECHNOLOGY CO., LTD.: COMPANY OVERVIEW   446

TABLE 565            AIPAK PHARMA: COMPANY OVERVIEW 447

LIST OF FIGURES

FIGURE 1              EMPTY CAPSULES MARKET SEGMENTATION & REGIONAL SCOPE            42

FIGURE 2              EMPTY CAPSULES MARKET: YEARS CONSIDERED    43

FIGURE 3              EMPTY CAPSULES MARKET: RESEARCH DESIGN                 46

FIGURE 4              EMPTY CAPSULES MARKET: BREAKDOWN OF PRIMARIES (DEMAND-

AND SUPPLY-SIDE PARTICIPANTS)         48

FIGURE 5              GLOBAL EMPTY CAPSULES MARKET SIZE ESTIMATION (SUPPLY-SIDE

ANALYSIS), 2024                 49

FIGURE 6              GLOBAL EMPTY CAPSULES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024             50

FIGURE 7              GLOBAL EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VOLUME (2024)              51

FIGURE 8              GLOBAL EMPTY CAPSULES VOLUME-BASED MARKET SIZE ESTIMATION,

BY VALUE (2024)               51

FIGURE 9              EMPTY CASPULES MARKET SIZE VALIDATION FROM PRIMARY EXPERTS             52

FIGURE 10            EMPTY CAPSULES SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH)                 53

FIGURE 11            GLOBAL EMPTY CAPSULES MARKET: CAGR PROJECTIONS (2025–2030)            55

FIGURE 12            EMPTY CAPSULES MARKET: DATA TRIANGULATION METHODOLOGY         57

FIGURE 13            EMPTY CAPSULES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)       60

FIGURE 14            GELATIN CAPSULES MARKET, BY RAW MATERIAL, 2025 VS. 2030 (USD MILLION)              61

FIGURE 15            NON–GELATIN CAPSULES MARKET, BY RAW MATERIAL,

2025 VS. 2030 (USD MILLION)      61

FIGURE 16            EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2025 VS. 2030 (USD MILLION) 62

FIGURE 17            EMPTY CAPSULES MARKET, BY SIZE, 2025 VS. 2030 (USD MILLION)       63

FIGURE 18            EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,

2025 VS. 2030 (USD MILLION)      63

FIGURE 19            EMPTY CAPSULES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)                64

FIGURE 20            REGIONAL SNAPSHOT OF EMPTY CAPSULES MARKET               65

FIGURE 21            INCREASING DEMAND FOR NUTRACEUTICALS AND PERSONALIZED SUPPLEMENTS TO PROPEL MARKET GROWTH             68

FIGURE 22            US AND GELATIN CAPSULES COMMANDED LARGER MARKET SHARES IN 2024             69

FIGURE 23            ANTIBIOTIC & ANTIBACTERIAL DRUGS SEGMENT ACCOUNTED FOR LARGEST SHARE IN EMPTY CAPSULES MARKET IN 2024         69

FIGURE 24            PHARMACEUTICAL INDUSTRY HELD LARGEST MARKET SHARE IN 2024 70

FIGURE 25            INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD         70

FIGURE 26            EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         71

FIGURE 27            TOTAL PRESCRIPTION DRUG SALES, 2016−2030 (USD BILLION) 74

FIGURE 28            NUMBER OF CLINICAL TRIALS REGISTERED, 2001−2024            74

FIGURE 29            EMPTY CAPSULES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES                 82

FIGURE 30            AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE,

2022−2024 (USD)              83

FIGURE 31            AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY REGION, 2024 (USD)          84

FIGURE 32            EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS            87

FIGURE 33            EMPTY CAPSULES MARKET: ECOSYSTEM ANALYSIS            89

FIGURE 34            EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES ANALYSIS           93

FIGURE 35            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR EMPTY CAPSULES             95

FIGURE 36            KEY BUYING CRITERIA FOR EMPTY CAPSULES, BY END USER     97

FIGURE 37            TOTAL NUMBER OF PATENTS GRANTED, 2014−2024            100

FIGURE 38            TOP TEN PLAYERS/APPLICANTS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014−2024                 100

FIGURE 39            EMPTY CAPSULES MARKET: VENTURE CAPITAL INVESTMENTS & NUMBER OF DEALS FOR SMALL MOLECULES, 2018–2024 (Q3)   119

FIGURE 40            AI USE CASES IN EMPTY CAPSULS MARKET                 121

FIGURE 41            NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT          253

FIGURE 42            ORAL SOLID DOSAGE (OSD) PERCENTAGE OF NOVEL DRUG APPROVAL,

2022–2024              258

FIGURE 43            ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT          296

FIGURE 44            REVENUE ANALYSIS OF KEY PLAYERS IN EMPTY CAPSULES MARKET, 2020–2024 (USD BILLION)   367

FIGURE 45            MARKET SHARE ANALYSIS OF KEY PLAYERS IN EMPTY CAPSULES MARKET (2024)            368

FIGURE 46            EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         371

FIGURE 47            EMPTY CAPSULES MARKET: COMPANY FOOTPRINT       372

FIGURE 48            EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2024                378

FIGURE 49            EV/EBITDA OF KEY VENDORS   381

FIGURE 50            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF

KEY VENDORS  381

FIGURE 51            EMPTY CAPSULES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS            382

FIGURE 52            CAPSUGEL (LONZA): COMPANY SNAPSHOT                 388

FIGURE 53            ACG: COMPANY SNAPSHOT        393

FIGURE 54            QUALICAPS (ROQUETTE FRÈRES): COMPANY SNAPSHOT          397

FIGURE 55            SUHEUNG: COMPANY SNAPSHOT            400

FIGURE 56            HEALTHCAPS INDIA: COMPANY SNAPSHOT                 404

FIGURE 57            NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT          406

FIGURE 58            SUNIL HEALTHCARE LIMITED: COMPANY SNAPSHOT          409

FIGURE 59            NATURAL CAPSULES LIMITED: COMPANY SNAPSHOT          411

FIGURE 60            QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): COMPANY SNAPSHOT          414

FIGURE 61            COMED CHEMICALS LIMITED: COMPANY SNAPSHOT          416

FIGURE 62            ANHUI HUANGSHAN CAPSULE CO., LTD.: COMPANY SNAPSHOT   418

FIGURE 63            FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): COMPANY SNAPSHOT             420

FIGURE 64            SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.): COMPANY SNAPSHOT                 422

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31
• 高純度ガス市場規模、シェア、動向、2030年までの世界予測 2025-10-30
• 動物用生物学的製剤市場規模、シェア、動向、2030年までの世界予測 2025-10-30
• エンジニアリング樹脂向け難燃剤市場規模、シェア、動向、2030年までの世界予測 2025-10-29
• アプリケーションモダナイゼーションサービス市場規模、シェア、動向、2031年までの世界予測 2025-10-29

MarketsandMarkets  出版レポート一覧